Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparing single versus multiple anti VEGF injections in diabetic patients undergoing cataract surgery
NCT07301775Phase 4Not yet recruiting
- Start
- Jan 2026
- Primary completion
- Jun 2026
- Modality
- Engineered Antibody Formats, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of aflibercept in diabetic retinopathy (DR), diabetic macular edema (DME). Planned start Jan 2026; status: not yet recruiting.
02
Drugs
aflibercept
03
Conditions
diabetic retinopathy (DR)diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT07301775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07301775.